Sort
30,917 grants matching “tumor microenvironment”
Project 2
$283,399Tomas Kirchhoff · New York University School Of Medicine · P50 · FY2021 · CA
Organoid Acquired Resistance
$283,289Sourav Bandyopadhyay · University Of California, San Francisco · U54 · FY2022 · CA
STINGel Immunotherapy for Treatment-Resistant Head and Neck Cancer
$283,286Simon Young · University Of Texas Hlth Sci Ctr Houston · R21 · FY2018 · DE
Project 2
$283,281Tomas Kirchhoff · New York University School Of Medicine · P50 · FY2022 · CA
Improving delivery of paclitaxel to ovarian cancer via expansile nanoparticles
$283,122Aaron Henry Colby · Ionic Pharmaceuticals · R43 · FY2017 · CA
Dysbiosis-induced impairment of tumoral leukocyte extravasation
$283,100Ruud P.m. Dings · Univ Of Arkansas For Med Scis · P20 · FY2019 · GM
Dysbiosis-induced impairment of tumoral leukocyte extravasation
$283,100Ruud P.m. Dings · Univ Of Arkansas For Med Scis · P20 · FY2018 · GM
Role of Surface Roughness in Regulating Tumor Cell Behavior
$283,076Sarah C Glover · University Of Florida · R01 · FY2011 · CA
PROJECT 3
$283,058Gary Joseph Smith · Univ Of North Carolina Chapel Hill · P01 · FY2009 · CA
The Role of Chemokines in Metastatic Prostate Cancer
$283,049University Of Michigan At Ann Arbor · R01 · FY2003 · DK
P-4: Targeting activation of NFkB pathways in MM
$283,044Peter Leif Bergsagel · Dana-Farber Cancer Inst · P50 · FY2012 · CA
Ras-mediated signals in human epithelial cell transformation and metastasis
$283,032Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Host MMP-mediated regulation of the vicious cycle of prostate to bone metastases
$283,026Conor C Lynch · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · CA
Chemotherapeutic Agents with Enhanced Selectivity for the Tumor Microenvironment
$282,992Kevin G Pinney · Baylor University · R01 · FY2011 · CA
Chemotherapeutic Agents with Enhanced Selectivity for the Tumor Microenvironment
$282,992Kevin G Pinney · Baylor University · R01 · FY2012 · CA
Role of S100A7 in breast cancer progression and metastasis
$282,912Ramesh K Ganju · Ohio State University · R01 · FY2013 · CA
Integrating Innate &Adaptive Immunity in Cancer Therapy
$282,892University Of Louisville · R01 · FY2004 · CA
Integrating Innate & Adaptive Immunity in Cancer Therapy
$282,884Nejat K Egilmez · State University Of New York At Buffalo · R01 · FY2008 · CA
Cell Processing and Immune Assessment
$282,875Jerome Ritz · Dana-Farber Cancer Inst · P01 · FY2013 · CA
miRNA-mediated Stromal Cell Survival under Stress Supports Breast Cancer Growth
$282,853Radhika R. Pochampally · University Of Mississippi Med Ctr · R01 · FY2014 · CA
Notch-1 and IGF-1 crosstalk: new therapeutic strategies for NSCLC
$282,852Maurizio Bocchetta · Loyola University Chicago · R01 · FY2013 · CA
Project 1: Molecular Mechanisms Initiating Prostate Cancer Metastasis
$282,822Leland W. Chung · Cedars-Sinai Medical Center · P01 · FY2017 · CA
Effects of MUC1 expression on erbB activity in neoplasia
$282,772Joyce A Schroeder · University Of Arizona · R01 · FY2007 · CA
Nanostructured Matrices for Cancer Cell Biology
$282,769Milan Mrksich · Northwestern University At Chicago · U54 · FY2011 · CA
TARGETING MYCN PROTEIN WITH SMALL MOLECULES
$282,760William A Weiss · Children'S Hospital Of Los Angeles · P01 · FY2012 · CA